By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Noven Pharmaceuticals Inc. 

11960 S.W. 144th Street

Miami  Florida  33186-5807  U.S.A.
Phone: 305-253-5099 Fax:


Company News
Noven Pharmaceuticals Inc. Appoints Krista Roberts As Vice President Of Operations 6/23/2014 8:50:55 AM
Pharma Firms Like Merck & Co., Inc. (MRK) And Noven Pharmaceuticals Inc. Flock To Miami 4/30/2014 8:16:07 AM
Noven Pharmaceuticals Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/17/2014 9:55:46 AM
Noven Pharmaceuticals Inc. Enters Co-Promotion Agreement With Shionogi, Inc. For Brisdelle™ (Paroxetine) Capsules 1/13/2014 12:08:31 PM
Noven Pharmaceuticals Inc. Release: First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies 11/5/2013 7:45:50 AM
Noven Pharmaceuticals Inc. Release: Data on Brisdelleā„¢ (Paroxetine) Capsules, the First and Only FDA-Approved Non-Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting of The North American Menopause Society 10/2/2013 9:55:23 AM
FDA Panel Votes Against Approval of Noven Pharmaceuticals Inc.'s Menopause Drug 3/5/2013 8:00:41 AM
FDA Accepts Noven Pharmaceuticals Inc.s NDA for an Investigational Nonhormonal Therapy for Menopausal Vasomotor Symptoms 11/13/2012 9:05:31 AM
Noven Pharmaceuticals Inc.'s Nonhormonal Hot Flash Therapy Meets Phase III Goals 10/3/2012 6:40:55 AM
Noven Pharmaceuticals Inc. (NOVN) Announces Commencement of Phase 2 Study of Investigational d-Amphetamine Transdermal System for ADHD 10/2/2012 10:18:14 AM